Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,546 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06961409Recruiting
Saliva markers test for gum health
This trial measures certain proteins in your saliva to understand how they relate to different stages of gum disease. If you're generally healthy and have not smoked or taken certain medications recently, you may be able to join and help researchers learn more about gum health.
Izmir, ÇiğliAges 18–70 - NCT07120464Recruiting
Rabies vaccine study for people with weak immune systems or older age
This study tests how well a rabies vaccine works and how safe it is for people whose immune systems may be weaker, such as those with certain long-term illnesses, organ transplants, or age 60 and older. It compares them to healthy adults ages 18 to 59.
Shenzhen, GuangdongAges Any age - NCT07125885Recruiting
Pregnancy and postpartum health study
This study follows women who are planning to become pregnant, are currently pregnant, or have recently given birth. It aims to learn more about health during pregnancy and after childbirth.
Shanghai, Shanghai MunicipalityAges 18–50 - NCT07124949Recruiting
Chinese migrant health study for older adults
This long-term study follows adults aged 60 and older who live in Harbin or Hainan to track their health over five years. It aims to understand health changes in this migrant population and does not involve any new treatments or drugs.
Harbin, HeilongjiangAges 60–120 - NCT07122544Recruiting
Salt chamber pulmonary rehab for COPD
This study tests whether doing pulmonary rehab (breathing and exercise training) in a salt chamber can help people with COPD breathe and feel better. It is for people whose COPD is stable and who can move independently.
Krakow, MałopolskaAges 18 years+ - NCT07120347Recruiting
Remote sensors to study daily activities in older adults with mild memory loss
This study uses remote sensors (like motion detectors) to see how older adults with mild memory or thinking problems go about their daily lives. It may help researchers learn how to better support people with early dementia.
Columbia, MissouriAges 50 years+ - NCT07098741Recruiting
Physical therapy for low back pain and pelvic tilt
This study looks at different physical therapy treatments for people with chronic, non-specific low back pain and a forward-tilted pelvis (anterior pelvic tilt). It aims to find which type of exercise or therapy works best to improve posture and reduce pain.
Chak Four Hundred Fifty-four, Punjab ProvinceAges 20–40 - NCT07087912RecruitingPhase 4
Dengue vaccine safety in people with autoimmune rheumatic diseases
This study tests the safety and immune response of a dengue vaccine in people aged 12–59 with stable autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) who are on low-dose or no immune-suppressing medications. It also includes healthy volunteers for comparison.
São Paulo, São PauloAges 12–59 - NCT05854368Recruiting
Blood tests to detect early stomach changes and cancer
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
Boulogne-BillancourtAges 18 years+ - NCT07077395RecruitingPhase 2
Hot flash study to check heart health links
This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.
Boston, MassachusettsAges 40–65 - NCT07044973Recruiting
Focused ultrasound for Parkinson's disease tremor
This trial uses focused ultrasound to treat tremor and movement problems in Parkinson's disease. It targets a specific brain area without surgery, and may help if your symptoms are worse on one side and not fully controlled by medication.
Beijing, Beijing MunicipalityAges 22 years+ - NCT06992986Recruiting
Urine Bacteria in Bladder Cancer vs. Other Conditions
This study compares the bacteria in urine of men with bladder cancer to those with other urinary issues and healthy men. For bladder cancer patients, it looks at differences before a planned surgery to remove the bladder.
RomeAges 50–70 - NCT07031661Recruiting
Bipolar disorder risk study for teens and children
This study follows children and teens who may be at higher risk for bipolar disorder to develop a prediction model. It includes three groups: those with a parent who has bipolar disorder, those with atypical depression, and healthy volunteers.
Shanghai, Shanghai MunicipalityAges 6–18 - NCT07025785Recruiting
Testing for tumor DNA in blood after early-stage breast cancer surgery
This study looks for tiny bits of tumor DNA in your blood after surgery to see if it can help guide future treatment. It's for people who had surgery first (not chemotherapy before surgery) and have not seen the cancer spread.
Chapel Hill, North CarolinaAges 18 years+ - NCT07020533RecruitingPhase 1
CMV vaccine for stem cell transplant recipients
This trial tests a vaccine designed to boost immunity against CMV (a common virus) and prevent active CMV infection in people receiving a half-matched stem cell transplant. It may help protect you from CMV-related complications after transplant.
Duarte, CaliforniaAges 18–75 - NCT07015684RecruitingPhase 1
Radioactive antibody and transplant for advanced sickle cell disease
This trial tests a radioactive antibody (131I-apamistamab) as part of conditioning before a stem cell transplant from a matched sibling donor. It aims to make the transplant safer and more effective for people with severe sickle cell disease.
New York, New YorkAges 12–50 - NCT07022197RecruitingPhase 1/Phase 2
BAFF-R CAR T cells for severe nerve and immune diseases
This trial tests a new treatment using your own immune cells (called BAFF-R CAR T cells) for people with severe nerve and immune diseases that have not improved with standard medicines. These cells are designed to target and destroy certain immune cells that may be causing your illness.
Tianjin, Tianjin MunicipalityAges 18–60 - NCT07021794RecruitingPhase 2
Antibody treatment for Long COVID symptoms
This study tests whether a lab-made antibody (sipavibart) can reduce Long COVID symptoms. It is for people who developed Long COVID after a confirmed COVID infection and still have moderate to severe fatigue and other ME/CFS-like symptoms.
Fort Lauderdale, FloridaAges 18–70 - NCT07006831Recruiting
Blood study for kidney transplant patients
This study collects blood and leftover donor samples from kidney transplant recipients who need a biopsy. The goal is to improve monitoring after transplant.
San Diego, CaliforniaAges 18 years+ - NCT06995521RecruitingPhase 2
Vorinostat for GVHD prevention in young adults with non-cancer conditions
This trial tests if the drug vorinostat can help prevent graft-versus-host disease (GVHD) in adolescents and young adults undergoing a stem cell transplant for non-cancerous blood, immune, or metabolic disorders. GVHD is a common complication where donor cells attack the recipient's body.
Ann Arbor, MichiganAges 1–26 - NCT06984510Recruiting
Early aging and diabetes risk with fatty liver
This study looks at how early biological aging might increase the chance of developing type 2 diabetes in people with a fatty liver (a condition called MASLD). It uses routine health check-up data to understand the link.
Ningbo, ZhejiangAges 20–90 - NCT06989749Recruiting
Brain stimulation for affect and pain study
This study tests if a gentle electrical current applied to the scalp can change how people feel pain and manage emotions. It may help researchers find new ways to help people with pain.
Hanover, New HampshireAges 18–55 - NCT06983808Recruiting
Digital rehab before heart surgery
This trial tests a digital program to help you prepare for heart surgery. It uses a smartphone or tablet to guide you through exercises and education before your operation, which may help you recover faster.
Melbourne, VictoriaAges 18–100 - NCT06974877RecruitingPhase 1
PET/CT Imaging for Amyloid in CAPS on Anakinra
This trial uses a special PET/CT scan to see if a radioactive tracer can measure changes in amyloid buildup in people with CAPS who have developed a skin reaction to anakinra. It may help doctors understand how the disease is affecting your organs.
Bethesda, MarylandAges 18–120
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,546 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.